Ivermectin labelled ‘possible treatment’ 29 months into pandemic

Ivermectin labelled 'possible treatment' 29 months into pandemic

Months after Health Canada claimed it’s “disinformation” to use ivermectin to treat COVID-19, the American health agency is considering the drug as a “possible treatment.”

Ivermectin labelled 'possible treatment' 29 months into pandemic
Ivermectin labelled ‘possible treatment’ 29 months into pandemic.

Under “COVID-19 Treatment Guidelines,” the National Health Institute’s (NIH) website lists ivermectin as “an antiparasitic drug that is being evaluated to treat COVID-19.”

The NIH’s current evaluation suggests ivermectin can be used to treat the novel coronavirus.

“Reports from in vitro studies suggest that ivermectin acts by inhibiting host importin alpha/beta-1 nuclear transport proteins, which are part of a key intracellular transport process,” the listing reads.

“Viruses hijack the process and enhance infection by suppressing the host’s antiviral response. In addition, ivermectin docking may interfere with SARS-CoV-2 spike protein attachment to the human cell membrane. Some studies of ivermectin have also reported potential anti-inflammatory properties, which have been postulated to be beneficial in people with COVID-19.”

The assessment explicitly recommends “against the use of ivermectin for the treatment of COVID-19, except in clinical trials.”

The most recent update to the NIH website is April 29, 2022. In the time since, a new peer-reviewed study involving almost 90,000 patients indicated that ivermectin significantly reduced the chances of hospitalization and death in COVID-infected individuals.

Ivermectin has been a controversial treatment for over two years, with health authorities on the government payroll censoring and shaming medical experts who argued it’s effective in treating COVID.

Canada’s state broadcaster CBC News ran a piece about COVID “disinformation” in which Health Canada stated there’s no evidence of the drug’s utility.

Canadian Heritage Minister Pablo Rodriquez — who is pushing for censorship of so-called “disinformation” through Bill C-11 — has alluded to censoring outlets that suggest ivermectin can treat COVID.

“We are having discussions internally because there’s no way that Canada Heritage will support any type of disinformation,” he said in March.

In May, the Missouri Legislature passed a bill preventing state licensing boards from punishing doctors who “lawfully” prescribe ivermectin or hydroxychloroquine to treat COVID.

“Unfortunately, because of the politicization of those two drugs, [doctors are] being targeted,” Sen. Rick Brattin said. “I wanted to protect them from that.”

Share this story

Donate now to keep us on the front lines:

Help Keep your News Free

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

[wpp limit=6 order_by='views']

YOU MIGHT ALSO LIKE THESE...

Trending News

Search results about about Prime Minister Justin Trudeau’s potential resignation hits an all-time high

Walid Tamtam

January 5, 2025

Trending News

According to publicly available records obtained from itineraries published by the Prime Minister’s official website, Justin Trudeau took 116 days off in 2024. 

Walid Tamtam

December 31, 2024

Trending News

Prime Minister Justin Trudeau has shuffled his cabinet yet again amid turmoil within the Liberal Party and speculation that he might quit.

Mike Campbell

December 20, 2024

Trending News

NDP leader Jagmeet Singh is now saying he’ll propose a non-confidence motion against Justin Trudeau in late January. Is this the end?

TCS Wire

December 20, 2024

Trending News

Trudeau to avoid taking questions from reporters for the fourth straight day since his Finance Minister quit cabinet and publicly trashed him.

Mike Campbell

December 19, 2024

Want to join the conversation?

Sign up now to be able to like, comment and reply to other members. A full membership to our site includes:

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.